Lithium and GSK3-&#946; promoter gene variants influence white matter microstructure in bipolar disorder by Benedetti, F. et al.
Lithium and GSK3-b Promoter Gene Variants Influence
White Matter Microstructure in Bipolar Disorder
Francesco Benedetti*,1,2, Irene Bollettini1,2, Ignazio Barberi3, Daniele Radaelli1,2, Sara Poletti1,2,
Clara Locatelli1,2, Adele Pirovano1, Cristina Lorenzi1, Andrea Falini2,4, Cristina Colombo1 and
Enrico Smeraldi1,2
1Istituto Scientifico Ospedale San Raffaele, Department of Clinical Neurosciences, Scientific Institute and University Vita-Salute, San Raffaele
Turro, Milan, Italy; 2C.E.R.M.A.C. (Centro di Eccellenza Risonanza Magnetica ad Alto Campo), University Vita-Salute San Raffaele, Milan, Italy;
3Dottorato in Neuroscienze e Disturbi del Comportamento, Dipartimento di Scienze Farmacologiche, Universita` degli Studi di Palermo, Milan,
Italy; 4Department of Neuroradiology, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy
Lithium is the mainstay for the treatment of bipolar disorder (BD) and inhibits glycogen synthase kinase 3-b (GSK3-b). The less active
GSK3-b promoter gene variants have been associated with less detrimental clinical features of BD. GSK3-b gene variants and lithium can
influence brain gray matter structure in psychiatric conditions. Diffusion tensor imaging (DTI) measures of white matter (WM) integrity
showed widespred disruption of WM structure in BD. In a sample of 70 patients affected by a major depressive episode in course of
BD, we investigated the effect of ongoing long-term lithium treatment and GSK3-b promoter rs334558 polymorphism on WM
microstructure, using DTI and tract-based spatial statistics with threshold-free cluster enhancement. We report that the less active GSK3-
b rs334558*C gene-promoter variants, and the long-term administration of the GSK3-b inhibitor lithium, were associated with increases
of DTI measures of axial diffusivity (AD) in several WM fiber tracts, including corpus callosum, forceps major, anterior and posterior
cingulum bundle (bilaterally including its hippocampal part), left superior and inferior longitudinal fasciculus, left inferior fronto-occipital
fasciculus, left posterior thalamic radiation, bilateral superior and posterior corona radiata, and bilateral corticospinal tract. AD reflects the
integrity of axons and myelin sheaths. We suggest that GSK3-b inhibition and lithium could counteract the detrimental influences of BD
on WM structure, with specific benefits resulting from effects on specific WM tracts contributing to the functional integrity of the brain
and involving interhemispheric, limbic, and large frontal, parietal, and fronto-occipital connections.
Neuropsychopharmacology (2013) 38, 313–327; doi:10.1038/npp.2012.172; published online 19 September 2012
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INTRODUCTION
Glycogen synthase kinase 3-b (GSK3-b) is an essential
element of the Wnt/beta-catenin pathway, which is involved
in the control of gene expression, cell behavior, cell adhesion,
and cell polarity, and has major roles in neurodevelopment
and regulation of neuronal polarity, neuronal plasticity, and
cell survival (Grimes and Jope, 2001b). GSK3-b is constitu-
tively active and regulates the activity of many targets,
including transcriptional factors, enzymes and cytoskeletal
proteins (Kockeritz et al, 2006). GSK3-b is considered a
primary regulator in a range of cellular processes, including
differentiation, growth, motility, and apoptosis: increasing
GSK3 activity increases apoptosis in neuronal cells, whereas
inhibiting GSK has neuroprotective effects (Forde and Dale,
2007). GSK3 is then considered a key factor in influencing the
susceptibility of neurons to harmful stimuli (neuronal
resilience) (Manji et al, 2000). Its inhibitory phosphorilation
occurs in response to neurotrophins, such as brain-derived
neurotrophic factor (BDNF), or to insulin or insulin-like
growth factor, or to secreted Wnt glycoproteins (Gould and
Manji, 2005).
Control of the phosphorylation/activity status of GSK3-b
is considered an important mechanism of serotonin (5-HT)
and dopamine (DA) action on brain and behavior (Beaulieu
et al, 2008). Converging studies in animal models showed
that inhibition of GSK3-b occurs in the context of the
signaling cascades in response to lithium, valproate, and
several antidepressants, such as selective 5-HT reuptake
inhibitors, monoamine oxidase inhibitors, and tricyclic
antidepressants, thus affirming an involvement of GSK3-b
in the regulation of behavior by the main drugs used in the
treatment of bipolar disorder (BD) (Beaulieu et al, 2009;
Gould and Manji, 2005). Lithium, in particular, can inhibit
GSK3-b both directly, by competing with magnesium, and
indirectly, by increasing its phosphorylation state via
inhibition of a protein phosphatase that normally activates
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GSK3-b (Jope, 2003). These mechanisms are likely to have a
key role in the neuroprotective effects of lithium (Quiroz
et al, 2010) and could be an essential part of the mechanism
of its therapeutics action in BD by correcting a proposed
impairment of cellular plasticity and resilience (Bachmann
et al, 2005).
To study the role of GSK3-b in BD, we and other groups
performed association studies bewteen core characteristics
of the illness and a promoter SNP ( 50 T/C; rs334558),
which in cultured human embryonic kidney HEK293 and
human neuroblastoma SK-N-MC cell lines was associated
with a significant 1.4-fold increase in transcriptional
strength of the wild T allele relative to the C allele, because
the C allele abrogates the binding of the activating
enhancer-binding protein 4 (AP4) transcriptional factor
(Kwok et al, 2005). The low-activity C allele was associated
with less detrimental clinical features of mood disorders,
including a delayed onset of illness (Benedetti et al, 2004a),
a better clinical response to lithium in the lifetime
prevention of illness recurrences (Benedetti et al, 2005),
and a better antidepressant response both to lithium
augmentation therapy of drug-resistant depressive episodes
(Adli et al, 2007) and to non-pharmacological antidepres-
sant treatment with sleep deprivation (Benedetti et al,
2004b). Genetic variation of GSK3-b activity was shown to
modulate the effects of genetic determinants of monoami-
nergic function: in rodents, the knockout of GSK3-b
counteracted the depressive-like behavioral effects of
genetic 5-HT inhibition (Beaulieu et al, 2008); in depressed
bipolar patients, either carrying the rs334558*C allele
(Benedetti et al, 2012) or being administered therapeutic
doses of lithium (Benedetti et al, 2008) could overcome the
detrimental influence of the short form of the 5-HT
promoter on antidepressant response.
GSK3-b gene variants and lithium can influence brain
structure in psychiatric conditions. rs334558*C itself was
associated with protective effects against gray matter (GM)
loss in schizophrenia (Benedetti et al, 2010), whereas other
SNPs either directly related to GSK3-b, or to its substrate
proteins, were associated with GM volumes in major
depressive disorder (Inkster et al, 2009, 2010). Lithium
administration was followed by an increase of GM volumes
in healthy humans (Monkul et al, 2007) and in patients
affected by BD (Bora et al, 2010), thus possibly counteracting
GM volume reductions in critical cortical areas (Benedetti
et al, 2011b). Pivotal prospective studies confirmed that the
lithium-associated GM volume increase during treatment
correlated with treatment response in BD (Lyoo et al, 2010;
Moore et al, 2009).
In recent years, diffusion tensor imaging (DTI) techni-
ques allowed to study the microstructure of white matter
(WM) in vivo. Given the microscopic structure of WM, in
normal conditions the integrity of myelinated axons limits
the diffusion of water in directions other than along the
main axis of the fiber (axial diffusivity (AD)). This tendency
to diffuse in one direction as opposed to all others, termed
anisotropy, can be estimated through the application of
diffusion-sensitizing gradients and the calculation of
elements of the diffusion tensor matrix, ie, the three
eigenvalues l1, l2, and l3. (Basser et al, 1994; Le Bihan,
2003; Taylor et al, 2004). A decrease of the tendency to
diffuse along the principal direction (l1) of the fiber, ‘axial
diffusivity’, suggests axonal loss or loss of bundle coher-
ence, and an increase in ‘radial diffusivity’ (the average of l2
and l3), perpendicular to axonal walls, suggests disrupted
myelination (Song et al, 2002). Mean diffusivity (MD,
average of l1, l2, and l3) is a measure of the average
molecular motion, independent of tissue directionality.
Fractional anisotropy (FA) is the square root of the sum of
squares (SRSSs) of the diffusivity differences, divided by the
SRSS of the three diffusivities, with values ranging between
0 and 1 depending on directionality of diffusivity.
Notwithstanding the many studies of BD performed on
mixed samples of patients with heterogeneous illness phases
and drug treatments, independent studies in selected
samples showed widespread changes of DTI measures in
untreated depressed patients (Benedetti et al, 2011c), drug-
naive patients with mania (Adler et al, 2006), untreated
patients with first episode psychosis (Lu et al, 2011), and
high-risk unaffected relatives of patients with BD (Sprooten
et al, 2011). Although these studies documented a wide-
spread increased diffusivity perpendicular to axonal walls,
with reduced FA in some areas, during illness phases of
opposite polarity, the few observations in stable euthymic
patients showed changes in the opposite direction, with
increased FA in patients with BD compared with controls
(Houenou et al, 2007; Wessa et al, 2009). These results
suggested that WM diffusivity changes in BD might be of
clinical relevance, with DTI providing new markers to
estimate the susceptibility to the disorder, to identify new
targets for treatment, and to predict and monitor treatment
efficacy.
The influence of GSK3-b and lithium on brain structure
could extend to the WM of bipolar patients, as also
suggested by our preliminary observations of a normalizing
effect of lithium on the WM tracts connecting amygdala and
subgenual cingulate (Benedetti et al, 2011a), and by a study
on twins showing that lithium could be protective against
the lobar WM loss associated with BD (van der Schot et al,
2009). GSK3-b inhibition by lithium and other compounds
promotes differentiation of oligodendrocytes from their
precursors, myelination, and remyelination of lesions in the
brain (Azim and Butt, 2011), as well as, in other districts,
recovery of spinal lesions (Dill et al, 2008) and differentia-
tion and myelination of Schwann cells (Ogata et al, 2004).
Consistent data showed that GSK3-b is critical for establish-
ing neuronal polarity, promoting neurite outgrowth, and
turning mature neurites into axons in CNS neurons
(Yoshimura et al, 2005). Axonal formation and elongation
has been observed in vitro in cultured mature neurons
derived from adult mammals when inhibiting GSK3-b with
lithium or other compounds, and in vivo in spinal cord
lesioned rats also treated with lithium, thus suggesting that
the role of GSK3-b and lithium in regulating the inherent
growth ability of neurons extends to mature cells (Dill et al,
2008). These effects have been linked with the ability of GSK
to influence the phosphorylation status of several micro-
tubule-binding proteins and to promote the assembly of
microtubules (Dill et al, 2008; Zhou et al, 2004).
Given that DTI is sensitive to factors affecting myelin and
axonal microstructure (Kinoshita et al, 1999), we hypothe-
sized that GSK3-b promoter gene variants and lithium,
which can influence axonal structures in mature neurons,
could also influence DTI measures of the tendency of water
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to diffuse into the brain, and in particular along the
principal direction of the WM fibers (AD, l1), which has
been shown to be a marker specifically sensitive to axonal
integrity and damage (Boretius et al, 2012). We tested this
hypothesis in the present study performed on a homo-
geneous sample of patients affected by a major depressive
episode in course of bipolar illness and either drug-free or
treated with lithium salts.
MATERIALS AND METHODS
Participants
We studied 70 consecutively admitted inpatients affected by
a major depressive episode, without psychotic features, with
a diagnosis of BD type I (structured clinical interview for
DSM disorders). Patients were either drug-free (n¼ 50) or
on treatment with lithium (n¼ 20). Exclusion criteria were:
additional diagnoses on axis I, mental retardation on axis II,
pregnancy, major medical and neurological disorders,
history of drug or alcohol abuse, or dependency. Physical
examination, laboratory tests, and electrocardiograms were
performed at admission. No patient had received electro-
convulsive therapy within 6 months prior to study
enrollment. Duration of illness and lifetime duration of
lithium treatment in months were assessed by the
psychiatrist in charge and an independent interviewer using
best estimation procedure, taking into account available
charts, case notes, and informations provided by at least
one relative (Leckman et al, 1982). Handedness was
assessed with the Edinburgh inventory (Oldfield, 1971).
After complete description of the study to the participants,
written informed consent was obtained. The study was
approved by the local Ethical Committee.
Genotyping
To genotype rs334558, DNA was extracted from whole blood
by a manual extraction, using the Illustra blood genomicPrep
Midi Flow kit (GE Healthcare, Milan, Italy). PCR was
performed with these primers: 50-GACGTCCGTGATT
GGCTC-30 and 50-AGCCCAGAG CCCTGTCAG-30. The PCR
reaction was carried out in 10ml volume containing 150ng
genomic DNA, 5 pM of each primer, 200mM each dNTP, 10
HotMaster Taq Buffer, 5U of HotMaster Taq DNA Poly-
merase (Eppendorf, Milan, Italy), and 0.5ml of dimethyl
sulfoxide solution (Sigma-Aldrich, Milan, Italy). After an
initial step of 2min at 94 1C, 35 cycles of amplification (20 s at
94 1C, 10 s at 60 1C, 25 s at 70 1C) and a final extension step of
10min at 70 1C were performed. An aliquot of PCR product
was digested using AluI (New England Biolabs, England, UK);
fragments were separated in agarose gels. Unrestricted
PCR product (CC genotype) had a size of 344 bp; complete
restriction (TT genotype) produces two bands of 220 and
124 bp.
In the light of the rare frequency of the mutant rs334558
C/C homozygote genotype, analyses were performed by
comparing rs334558 T/T wild-type homozygotes with
pooled heterozygote and homozygote carriers of the mutant
C allele. This approach was justified by previous observa-
tions showing that (a) heterozygotes and homozygote
carriers of the C allele showed similar differences from
T/T homozygotes in the acute (Adli et al, 2007) and long-
term (Benedetti et al, 2005) clinical response to lithium,
which targets GSK3-b, and that (b) the effect on GM in
schizophrenia was the same in T/C and C/C, which both
differed from T/T (Benedetti et al, 2010), thus suggesting
that all C carriers could share the same biological reactivity
to these challenges.
Image Acquisition
DTI was performed on a 3.0 Tesla scanner (Gyroscan Intera,
Philips, the Netherlands) using SE Eco-planar imaging and
the following parameters: TR/TE¼ 8753.89/58msec, FoV
(mm) 231.43 (ap), 126.50 (fh), 240.00 (rl); acquisition matrix
2.14 2.71 2.31; 55 contiguous, 2.3-mm thick axial slices
reconstructed with in-plane pixel size 1.88 1.87mm2;
SENSE acceleration factor¼ 2; 1 b0 and 35 non-collinear
directions of the diffusion gradients; b value¼ 900 sec/mm2.
Fat saturation was performed to avoid chemical shift
artifacts. On the same occasion and using the same magnet
22 Turbo Spin Echo, T2 axial slices (TR¼ 3000ms; TE¼ 85
ms; flip angle¼ 90 1; turbo factor 15; 5-mm thick axial slices
with a 512 512 matrix and a 230 230mm2 field of view)
were acquired to rule out brain lesions.
Data Processing and Analyses
Image analyses and tensor calculations were done using the
‘Oxford Center for Functional Magnetic Resonance Imaging
of the Brain Statistical Library’ (FSL 4.1.4; www.fmrib.ox.-
ac.uk/fsl/index.html) (Smith et al, 2004; Woolrich et al,
2009). First, each of the 35 DTI volumes was affine
registered to the T2-weighted b¼ 0 volume using FLIRT
(FMRIB’s Linear Image Registration Tool) (Jenkinson and
Smith, 2001). This corrected for motion between scans and
residual eddy–current distortions present in the diffusion-
weighted images. In addition, trained reasearchers blind to
diagnosis manually inspected each volume of each image to
check for head motion artifacts: scans rated as 0 (none) had
little or no detectable motion artifact, those rated as 1 (mild)
had enough detectable motion to result in subtle concentric
bands, 2 (moderate) had significant banding, whereas those
rated as 3 (severe) were so extreme that the data were
deemed unreliable for analyses (Blumenthal et al, 2002).
After removal of nonbrain tissue (Smith, 2002), least-square
fits were performed to estimate the FA, eigenvector, and
eigenvalue maps. MD was defined as the mean of all three
eigenvalues ((l1þ l2þ l3)/3), AD as the principal diffusion
eigenvalue (l1), and RD as the mean of the second and third
eigenvalues ((l2þ l3)/2).
Next, all individuals’ volumes were skeletonized and
transformed into a common space as used in tract-based
spatial statistics (Smith et al, 2006; Smith et al, 2007). TBSS
focuses on the centers of all fiber bundles that are common
to the participants (the most compact WM skeleton), thus
improving the probability that the given spatial voxels
contain data from the same part of the same WM tract of
each participant. Briefly, all volumes were nonlinearly
warped to the FMRIB58_FA template supplied with FSL
(http://www.fmrib.ox.ac.uk/fsl/tbss/FMRIB58_FA.html) and
normalized to the Montreal Neurological Institute (MNI)
space, by use of local deformation procedures performed by
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FMRIB’s NonLinear Image Registration Tool (FNIRT)
(www.fmrib.ox.ac.uk/fsl/fnirt/index.html), a nonlinear re-
gistration toolkit using a b-spline representation of the
registration warp field (Rueckert et al, 1999). The common
template used in the present study is a high-resolution
average of 58 FA volumes from healthy male and female
subjects aged 20–50 years. All warped FA volumes were
visually inspected for accuracy, which is especially pertinent
when analyzing data sets with broad age ranges with
relatively large interindividual variability in brain
size and architecture. FNIRT has been shown to perform
the native-to-standard warping adequately across several
age groups, including children and adolescents (Westlye
et al, 2010). Next, a mean FA volume of all subjects was
generated and thinned to create a mean FA skeleton
representing the centers of all common tracts. We
thresholded and binarized the mean skeleton at FA40.20
to reduce the likelihood of partial voluming in the
borders between tissue classes, yielding a mask of 137 833
WM voxels. Individual FA values were warped onto this
mean skeleton mask by searching perpendicular from the
skeleton for maximum FA values. Using maximum FA
values from the centers of the tracts further minimizes
confounding effects attributable to partial voluming
(Smith et al, 2006). The resulting tract invariant skeletons
for each participant were fed into voxelwise permutation-
based cross-subject statistics. Similar warping and analyses
were used on MD, AD, and RD data sampled from voxels
with FA40.20.
To investigate the effect of GSK3-b rs334558, we ran a
permutation-based nonparametric inference to investigate
the differences between the two groups of rs334558*C
carriers and T/T homozygotes. Given that lithium showed
progressive effects on GM structure during treatment in BD
(Lyoo et al, 2010; Moore et al, 2009), to investigate the effect
of lithium, we correlated the duration of lithium treatment
in months with DTI measures of WM microstructure. We
accounted for the effects of nuisance covariates which could
influence WM structure: age (Kochunov et al, 2007), sex
(Herting et al, 2011), and age at onset of illness. Voxelwise
DTI analyses were performed using nonparametric permu-
tation-based testing (Nichols and Holmes, 2002) as
implemented in randomized FSL. We tested for linear
effects of genotype and of lithium on FA, MD, AD, and RD
across the WM skeleton with general linear models (GLMs).
Threshold-free cluster enhancement (TFCE) (Smith and
Nichols, 2009) was used to avoid defining arbitrary cluster-
forming thresholds and smoothing levels. TFCE is particu-
larly useful when the spatial correlation length of signal
exceeds that of noise, as it is expected when studying WM
tracts. It can be seen as a generalization of the cluster mass
statistics (Bullmore et al, 1999), using spatial neighborhood
information in a nonlinear image processing to increase
sensitivity and boosting the height of spatially distributed
signals, without changing the location of their maxima.
Voxelwise levels of significance, corrected for multiple
comparisons, were then calculated with a standard
permutation testing by building up the null distribution
(across permutation of the input data) of the maximum
(across voxels) TFCE scores, and then using the 95th
percentile of the null distribution to threshold signals
at corrected po0.05. The data were tested against an
empirical null distribution generated by 5000 permutations
for each contrast, thus providing statistical maps fully
corrected for multiple comparisons across space. Corrected
po0.05 in a minimum cluster size of k¼ 100 was
considered significant.
To confirm and estimate effect sizes, values were then
extracted at signal peaks and compared among
genotype groups with an analysis of variance (ANOVA)
performed in the context of the GLM (McCulloch et al, 2008;
Timm and Kim, 2006). The independent variables
were GSK3-b rs334558 genotype (between groups) and
localization of the clusters (within groups), the DTI
measures in the peak difference voxels were the dependent
variables, and age was considered as nuisance covariate.
The significance of the effect of the single factors
on the dependent variables was estimated (least squares
method) by parametric estimates of predictor variables and
following the standard computational procedures (Hill and
Lewicki, 2006).
RESULTS
Clinical and demographic characteristics of the sample are
shown in Table 1.
No difference was statistically significant. The distribu-
tion of genotypes was T/T 26/70 (37.1%), T/C 34/70
(48.6%), and C/C 10/70 (14.3%), thus respecting the
Hardy–Weinberg equilibrium (w2¼ 0.043, p¼ 0.834). Allelic
frequencies (T 61.4% and C 38.6%) were closely similar to
those previously observed in healthy subjects (Russ et al,
2001) and in patients affected by BD (Benedetti et al,
2004b, Benedetti et al, 2005) or schizophrenia (Benedetti
et al, 2010).
GSK3-b rs334558 influenced DTI measures (Table 2). We
observed increases of AD and MD in C carriers compared
with T/T homozygotes, in most part of the brain WM tracts
(Figure 1).
Differences in AD were observed in three main clusters,
which included corpus callosum, cingulum bundle (includ-
ing its hippocampal part), uncinate fasciculus, superior and
inferior longitudinal fasciculus, corona radiata, and thala-
mic radiation (see listing in Table 2). AD values extracted
from the three signal peaks (Figure 2) were entered the GLM
ANOVA, which confirmed a global highly significant effect
of rs334558 on AD values (F¼ 16.29; df¼ 1,67; p¼ 0.0001.
Effect size: partial Z2¼ 0.20, power¼ 0.98), which was
significant in every cluster (L Corona Radiata: F¼ 6.88;
df¼ 1,67; p¼ 0.0108. R Corona Radiata: F¼ 9.53; df¼ 1,67;
p¼ 0.0029; R Superior Longitudinal Fasciculus: F¼ 5.46;
df¼ 1,67; p¼ 0.0224).
The values of AD in the three clusters significantly
differed (L4R, and Corona Radiata4SLF; F¼ 5.145; df¼ 2,
134; p¼ 0.0070), but there was no significant interaction of
rs334558 and localization, thus suggesting that the effect of
GSK3-b rs334558 was homogeneous in these regions.
Lithium influenced DTI measures (Table 3). Duration of
lithium treatment positively correlated with AD and MD in
several WM tracts, mainly in the left hemisphere (Figure 3).
Differences in AD were observed in two main clusters,
which included several of the tracts where an influence of
GSK was detected: callosum, cingulum, uncinate, superior
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and inferior longitudinal fasciculi, and corona radiata (see
listing in Table 3). Values extracted from the signal peak (at
24  54 27) and from the body of the callosum (at 0 16 19)
significantly correlated with duration of lithium treatment
(Figure 4: r¼ 0.347, p¼ 0.00325 and r¼ 0.481, p¼ 0.000025,
respectively).
The effects of GSK3-b rs334558 and lithium on AD
overlapped in several tracts. The WM tracts where both
factors had a significant effect (see Figure 5) were corpus
callosum, forceps major, anterior and posterior cingulum
bundle (bilaterally including its hippocampal part), left
superior and inferior longitudinal fasciculus, left inferior
fronto-occipital fasciculus, left posterior thalamic radiation,
bilateral superior and posterior corona radiata, and bilateral
corticospinal tract.
No significant effect was observed for FA and RD values
in any analysis.
DISCUSSION
We observed that the less active GSK3-b rs334558*C gene-
promoter variants, and the long-term administration
of the GSK3-b inhibitor lithium, were associated with
increases of DTI measures of AD and MD in WM fiber
tracts. The increase of MD was likely driven by the increase
of AD, given that RD was not significantly influenced by the
two factors.
AD represents the water diffusivity parallel to the axonal
fibers, reflecting the greater freedom of water to diffuse
along the principal fiber axis rather than to travel across the
surrounding myelin sheaths. Both myelin and axonal
microstructure, including microtubules and neurofilaments
(Kinoshita et al, 1999), contribute to this diffusion
anisotropy. Studies on neurodevelopment associated AD
with fiber diameter or organization (Takahashi et al, 2000).
Table 1 Clinical and Demographic Characteristics of the Sample Divided According to GSK3-b rs334558 Genotype and Ongoing Lithium
Treatment
Genotyping T/T homozygotes (n¼ 26) C carriers (n¼ 44) t or v2 (df¼ 68 or 1) p
Age 45.77±11.79 45.75±11.4 0.01 0.99
Sex (F/M) 19/7 31/13 0.06 0.81
Education (years at school) 11.42±4.4 10.79±3.52 0.62 0.53
Age at onset 30.19±9.63 29.61±9.41 0.25 0.81
Duration of illness (years) 15.61±9.6 15.93±10.43 0.13 0.90
Duration of lithium treatment (months) 46.23±67.69 39.88±62.07 0.40 0.69
Previous manic episodes (n) 3.7±5.42 2.98±2.98 0.69 0.49
Previous depressive episodes (n) 5.39±5.56 5.02±4.94 0.27 0.79
Head motion scores 1.04±0.66 0.86±0.76 0.96 0.34
Handedness 16.91±8.54 12.93±9.49 1.76 0.09
Lithium treatment Lithium-treated (n¼20) Lithium-free (n¼ 50) t or v2 (df¼ 68 or 1) p
Age 44.8±9.57 46.14±12.2 0.44 0.66
Sex (F/M) 11/9 39/11 3.70 0.06
Education (years at school) 10.94±2.95 11.06±4.17 0.11 0.91
Age at onset 30.3 ±7.34 29.64±10.2 0.26 0.79
Duration of illness (years) 14.5±8.63 16.34±10.61 0.69 0.49
Previous manic episodes (n) 4.00±3.20 2.91±4.29 0.99 0.32
Previous depressive episodes (n) 4.10±3.40 5.6±5.68 1.07 0.29
Head motion scores 1.00±0.65 0.9±0.76 0.52 0.61
Handedness 16.55±8.06 13.55±9.68 1.22 0.22
Lithium and genotyping T/T (n¼8) C carriers (n¼ 12) T/T (n¼18) C carriers (n¼ 32) F or v2 (df¼66, 3 or 3) p
Age 47.37±9.13 43.08±9.86 45.05±12.97 46.75±11.91 0.36 0.78
Sex (F/M) 6/2 5/7 13/5 26/6 6.78 0.08
Education (years at school) 11.33±2.58 10.73±3.23 11.44±4.93 10.82±3.68 0.13 0.94
Age at onset 33.37±10.49 28.25±3.39 28.78±9.18 30.12±10.85 0.56 0.64
Duration of illness (years) 14±8.5 14.83±9.07 16.33±10.2 16.34±10.99 0.16 0.92
Previous manic episodes (n) 4.57±4.47 3.67±2.35 3.31±5.88 2.69±3.2 0.48 0.7
Previous depressive episodes (n) 5.86±4.52 3.08±2.15 5.19±6.08 5.83±5.55 0.86 0.47
Head motion scores 1.25±0.46 0.83±0.72 0.94±0.72 0.87±0.79 0.64 0.59
Handedness 19.68±4.46 14.47±9.37 15.69±9.69 12.35±9.61 1.53 0.21
No difference was statistically significant (Student’s t-test, one-way ANOVA, or w2 test as appropriate).
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Animal models associated a reduction of AD with axonal
injury (Boretius et al, 2012; Song et al, 2003; Sun et al,
2006), and conversely associated an increase of RD with
unchanged AD with dysmyelination (Song et al, 2002). Over
the human lifespan, AD and MD decrease initially, and then
increase later in life (Lebel et al, 2012; Qiu et al, 2008), also
reflecting changes in fiber coherence and tortuosity (Dubois
et al, 2008).
The effects of lithium and rs334558 overlapped in most
part of the affected WM tracts, thus suggesting possible
common neurobiological mechanisms. Given that lithium
inhibits GSK, and the rs334558*C allele has been associated
with a lower expression of GSK, these common mechanisms
could directly involve GSK3-b activity or its substrate
proteins. Several non-alternative mechanisms could con-
tribute to the converging effects of the GSK3-b promoter
polymorphism and lithium on AD by influencing the
characteristics of both myelin and axonal microstructure,
which are considered the neurobiological underpinnings of
this DTI measure.
Concerning axonal microstructure, GSK3-b has a key
regulatory role in establishing and mantaining neuronal
polarity (Yoshimura et al, 2006; Yoshimura et al, 2005).
As summarized in the Introduction section, inhibition of
GSK3-b by lithium promotes axonal formation and
elongation in mature neurons, also promoting the
assembly of microtubules (Dill et al, 2008; Namekata
et al, 2012; Zhou et al, 2004), which contribute to the
preferential diffusion along the principal fiber axis of
the fibers (Kinoshita et al, 1999), measured with the
eigenvalue l1 in DTI. Increasing activity of GSK3-b
in vitro inhibits axon formation, whereas both lithium
and other selective inhibitors of GSK3-b cause the
formation of multiple axons at the expenses of dendrites,
a process probably limited by the availability of mem-
brane and cytoplasmic materials (Jiang et al, 2005).
Several mechanisms contribute to this effect. BDNF has
a key role in the differentiation and neuritogenesis of
developing neurons and in the synaptic plasticity of
mature neurons: downstream of BDNF signaling, the axon
growth induced by neurotrophins is mediated by localized
inactivation of GSK3-b (Zhou et al, 2004), which promotes
axon branching and microtubule assembly (Namekata
et al, 2012), and lithium significantly elevates the
expression and production of BDNF in vitro (Su et al,
2009) and in vivo (de Sousa et al, 2011; Leyhe et al,
2009). Inhibition of GSK3-b by lithium also increases
the neurite outgrowth mediated by the neurotrophic
pituitary adenylate cyclase-activating polypeptide
(Zhang et al, 2009). Lithium-induced neurite outgrowth
is also mediated by an increased phosphorylation of
extracellular-signal regulated kinases (Wang et al, 2011)
and by an upregulated expression of sorting nexin 3
(Mizutani et al, 2009), but the effects of lithium on axonal
structures also involve altered levels of expression of
genes whose function has not yet been fully elucidated
(Italia et al, 2011).
Concerning myelin, GSK3-b inhibition by lithium and
other compounds promotes differentiation of oligodendro-
cytes from their precursors, myelination, and remyelination
of lesions in the brain (Azim and Butt, 2011). This
pivotal study showed that GSK3-b inhibition promotes the
Table 2 Comparison of GSK3-b rs334558*C Carriers with T/T
Homozygotes
Axial diffusivity No. of voxels and
signal peaks
(X, Y, Z)
White matter
tracts
T/T¼ 11.92±1.59
C carriers¼
12.37±1.6
7618
 20  17 40
(L corona radiata)
Forceps minor
Genu of corpus callosum
Body of corpus callosum
Splenium of corpus callosum
Forceps major
Cingulum bundle
Uncinate fasciculus L
Superior longitudinal fasciculus L
Inferior longitudinal fasciculus L
Inferior fronto-occipital fasciculus
L
Anterior thalamic radiation L
Corticospinal tract L
Anterior corona radiata L
Superior corona radiata L
Posterior corona radiata L
3114
21  26 40
(R corona radiata)
Forceps minor
Body of corpus callosum
Cingulum bundle R
Superior longitudinal fasciculus R
Superior corona radiata R
Corticospinal tract R
2740
37  44 30
(R superior
longitudinal fasciculus)
Splenium of corpus callosum
Forceps major
Cingulum bundle R
Hippocampus R
Superior longitudinal fasciculus R
Inferior longitudinal fasciculus R
Posterior thalamic radiation R
Inferior fronto-occipital fasciculus
R
Mean diffusivity No of voxels and
signal peaks
(X, Y, Z)
White matter
tracts
T/T¼ 7.3±0.38
C carriers¼
7.56±0.35
2620
 26 20 26
(L uncinate fasciculus)
Forceps minor
Body of corpus callosum
Cingulum L
Uncinate fasciculus L
Inferior fronto-occipital fasciculus
L
Anterior thalamic radiation L
Corticospinal tract L
Superior corona radiata L
1820
23  13 7
(R posterior limb of
internal capsule)
Cerebral peduncle R
Posterior limb of internal capsule
R
Corticospinal tract R
External capsule R
Anterior thalamic radiation R
Anterior limb of internal capsule R
Superior longitudinal fasciculus R
286
 28 23 32
(L anterior thalamic
radiation)
Superior longitudinal fasciculus L
In the first column, values of the DTI measures of AD and MD (means±SD) are
given for for regions showing maximal differences of TBSS values (signal peak).
The second column shows dimensions of clusters (number of voxels, mm3) and
localization of signal peaks (MNI coordinates). The third column lists the WM
tracts significantly affected by genotype in the clusters.
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proliferation of oligodendrocytes precursors and their
differentiation into mature oligodendrocytes both in vivo
in the adult and in the developing brain and ex vivo in
organotypic cultures of optic nerve, and confirmed that
when GSK3-b is inhibited by lithium, these effects involve
an interaction between the Wnt pathway and other
mechanisms (Azim and Butt, 2011). In particular, GSK3-b
inhibition increases proliferation of oligodendrocytes pre-
cursors via the canonical Wnt-b-catenin pathway, but Wnt
activation then hampers the differentiation of precursors
into myelinating oligodendrocytes (Fancy et al, 2009;
Feigenson et al, 2009). Direct inhibition of GSK3-b by
lithium and other compounds, however, enhances activa-
tion of the cyclic AMP response element binding (CREB)
Figure 1 WM areas where GSK3-b rs334558*C carriers showed significantly higher values of axial diffusivity (AD) than T/T homozygotes. Voxels of
significant group difference are mapped on the mean FA template of the studied sample and are shown in glass-brain images. The color bar refers to 1 p
values for the observed differences. Numbers are Z coordinates in the standard Montreal Neurological Institute (MNI) space.
Lithium and GSK3-b effects on white matter
F Benedetti et al
319
Neuropsychopharmacology
protein (Grimes and Jope, 2001a), which stimulates
oligodendrocytes differentiation (Pende et al, 1997), and
decreases Notch1 signaling (Azim and Butt, 2011), which
inhibits oligodendrocytes differentiation (Wang et al, 1998):
these two mechanisms override the negative effect of Wnt
activation on oligodendrocytes differentiation, and the net
effect of GSK3-b inhibition with lithium then increase
both the proliferation of oligodendrocytes precursors and
their differentiation into mature oligodendrocytes
(Azim and Butt, 2011). Moreover, lithium could influence
oligodendrocytes and the lipid composition of myelin by
inducing BDNF. BDNF has an impact on the proliferating
population of oligodendrocyte lineage cells and regulates
the numbers of progenitors and the abilities of cells to
express myelin proteins (VonDran et al, 2011), and
promotes cholesterol byosynthesis, which is essential for
synapse development in cultured neurons (Suzuki et al,
2007) and for myelin generation and repair (Dietschy and
Turley, 2004). Postmortem gene expression, neuropatholo-
gical, and neuroimaging studies suggest downregulation
of key oligodendrocyte and myelination genes (Tkachev
et al, 2003), as well as lowered number, size, and density
of oligodendroglial cells in BD patients (Carter, 2007;
Rajkowska, 2002; Uranova et al, 2004). This glial reduction
in mood disorders (Manji et al, 2001), paralleled by in vivo
changes of DTI measures (Benedetti et al, 2011c) and brain
WM volumes, has been associated with the genetic risks to
develop BD (van der Schot et al, 2009): GSK3-b inhibition
by lithium could act as a protective mechanism against
these effects.
Several other mechanisms affecting brain cellular struc-
tures, and thus modifying the tendency of water to diffuse
along the principal axis of the fiber, could be involved as
well. Autophagy, one of the principal responses to cellular
stress and a core regulator of neuronal survival and
function, is promoted by lithium (Chiu and Chuang,
2010). Inhibitors of GSK3-b, including lithium, can reduce
migration of microglia and inflammation-induced neuronal
toxicity (Yuskaitis and Jope, 2009), and could then counter-
act putative inflammation-induced changes of brain DTI
measures associated with BD, and which resulted in a loss
of diffusion anisotropy (Benedetti et al, 2011c). Adding to
its effect on GSK and BDNF, lithium modulates many
neurotransmitters and adjusts signaling activities regulating
second messengers, transcription factors, and gene expres-
sion (Jope, 1999), and it influences many cellular mechan-
isms involved in neurotrophic and neuroprotective effects,
including cyclic adenosine monophosphate (cAMP)-
mediated signal transduction, CREB activation, the phos-
phatidylinositide cascade, protein kinase C, and B-cell
lymphoma 2 expression (Quiroz et al, 2010). Lithium
markedly increases the neuroprotective protein Bcl-2 in the
same prefrontal cortical layers where, in patients, a
postmortem reduction of neuronal and glial cells has been
reported (Chen et al, 1999). Lithium modulates the
expression of structural postsynaptic genes with topo-
graphic specificity in cortical and subcortical regions, such
as Homer, Shank, and Inositol 1,4,5-trisphosphate receptor
(de Bartolomeis et al, 2012), and causes quantitative
perturbations in postsynaptic density proteome linked to
several key signaling pathways (Nanavati et al, 2011). GSK3
inhibition not only affects the Wnt cascade but also
influences other mechanisms; eg, it regulates AMPA-
induced GluR1 and GluR2 internalization via phosphoryla-
tion of kinesin light chain 2, the key molecule of the kinesin
cargo delivery system, thus regulating synaptic plasticity
and behavior (Du et al, 2010). Akt and GSK3 integrate 5-HT
and DA neurotransmission, and also provide a link between
the action of these neurotransmitters and gene products,
like disrupted in schizophrenia 1 and neuregulin, that are
associated with both cell structure and risk for mental
illness (Beaulieu, 2012). Moreover, at the cellular level, clock
genes could provide a mechanism for the control of
circadian gene expression and responsivity to stimuli
(Dallaspezia et al, 2011; Kondratov et al, 2006), and
GSK3-b is a core costituent of the mammalian circadian
clock and affects circadian rhythm generation by modifying
the stability of circadian clock molecules (Iitaka et al, 2005).
Effects on neural and synaptic plasticity within key
circuits have been proposed as core mechanisms of the
therapeutic action of lithium (Schloesser et al, 2011), and
the hypothesis that changes in WM microstructure could be
part of the mechanism of action of lithium is in agreement
with data on WM imaging in BD (Brambilla et al, 2009),
with recent perspectives emphasizing the therapeutic
relevance of the effects of psychotropic drugs on myelina-
tion and lipid homeostasis (Bartzokis, 2011; Bartzokis et al,
2009; Vik-Mo et al, 2009), and with recent findings in other
psychiatric conditions, suggesting that changes of DTI
measures could reflect a yet unexplored part of the
mechanism of action of psychotropic drugs (Benedetti
et al, 2012).
Existing literature on the relationship between DTI
measures, BD, and brain functions suggests that a higher
directionality of water diffusion along the main axis of the
WM fiber tracts could at least partly explain why lithium
treatment and the GSK3-b rs334558*C gene-promoter
variant have been associated with less detrimental features
of BD. A lower directionality of water diffusion in the same
WM tracts where lithium and GSK3-b rs334558*C increased
AD has been associated with BD (Benedetti et al, 2011c;
Lu et al, 2011). These localizations include key WM tracts
Figure 2 Values of AD extracted at signal peaks in the three clusters
where GSK3-b rs334558*C carriers showed significantly higher values of
AD than T/T homozygotes. Columns are means, error bars are SEM.
Differences among genotypes were significant in all regions.
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contributing to the functional integrity of the brain.
Compromised communication involving interhemispheric
connections, limbic, and large frontal, parietal, and fronto-
occipital connections could be a major biological under-
pinning of the hypothesized brain network dysfunctions,
leading to the cognitive and emotional deficits typical of BD
(Brambilla et al, 2009), and could contribute to explain the
abnormal effective cortico-limbic connectivity observed
with functional MRI in bipolar patients (Arnone et al,
2008; Rich et al, 2008).
Following this perspective and considering our results
and existing literature on mood disorders, specific benefits
Figure 3 WM areas where duration of lithium treatment significantly correlated with higher AD. Voxels of significant positive correlation are mapped on
the mean FA template of the studied sample and are shown in glass-brain images. The color bar refers to 1 p values for the observed differences. Numbers
are Z coordinates in the standard MNI space.
Lithium and GSK3-b effects on white matter
F Benedetti et al
321
Neuropsychopharmacology
for patients with BD could come from an increased AD in
specific WM tracts. Hippocampal dysfunction and atrophy
associates with mood disorders (Small et al, 2011), and in
normal and neurodegenerative conditions, DTI measures
of WM microstrucure of the hippocampal part of the
cingulum bundle correlate with memory scores and
hippocampal volume (Sexton et al, 2010). The cingulum
bundle integrates disparate modular brain systems involved
in attention, memory, and emotion regulation, and in mood
disorders, a higher directionality of water diffusion in the
cingulum bundle associates with better hedonic tone
(Keedwell et al, 2012), better cognitive performance
(Schermuly et al, 2010), and less psychomotor slowing
(Walther et al, 2012). The number of fibers within the
uncinate fasciculus inversely correlated with depression
severity (Zhang et al, 2012). Executive function and
processing speed were correlated with anisotropy of the
anterior thalamic radiation and uncinate fasciculus in late
life depression (Sexton et al, 2011). Abnormal myelination
and morphometry of callosum interhemispheric connec-
tions have been consistently associated with BD
(Bearden et al, 2011) and dimensions of BD psychopatology,
such as aggression (Saxena et al, 2012) and suicide (Matsuo
et al, 2010).
Altogether, these findings support the interest for DTI
measures of WM microstructure as individual biomarkers
in patients with BD and confirm the hypothesis that GSK
inhibition and lithium could counteract the detrimental
influences of BD on WM structure (Benedetti et al, 2011a).
These effects on WM could parallel the effects on GM (see
Introduction) and contribute to the global benefit for the
patient.
Strengths of the present study include a focused research
question and state-of-the-art imaging methods, but our
results must be viewed in light of several methodological
limitations. Animal models of DTI measures have been
mainly developed to test toxic, but not therapeutic, effects
of drugs (Harsan et al, 2006), and this limits the specificity
of diffusion measures for the neurobiological effects of
drugs. Sample size allowed to define effects of lithium use
and protective GSK3-b rs334558 variants in the same brain
regions (Figure 5), but did not allow to test specific
interactions between the two factors (eg, comparing lithium
effects among genotypes or genotype effects among
subgroups defined by the duration of the treatment). Again,
we obtained an excellent power to study a single
polymorphism, but could not consider other gene–gene
and gene–environment interactions, and their interaction
with clinical variables. There was no placebo control for
lithium administration. The duration of lithium treatment
was estimated retrospectively, thus being biased by the
impossibility to assess compliance. Patients were non drug-
naive, and the drug treatments administered during the
course of the illness could have influenced DTI measures,
alone or interacting with lithium salts. Recruitment was in a
single center and in a single ethnic group, thus raising the
possibility of population stratifications, limiting the gen-
eralizability of the findings.
In conclusion, these limitations do not bias the main
finding of overlapping effects of lithium use and protective
GSK3-b rs334558 in WM tracts, which (1) suggests a shared
mechanism to be further confirmed and explored in
enlarged and independent samples and (2) confirms the
usefulness of DTI for the study of the brain structural
changes associated with BD.
Table 3 Correlation of the Duration of Lithium Treatment with
DTI Measures
Axial
diffusivity
No. of voxels and
signal peaks
(X, Y, Z)
White matter tracts
13.61±2.37 6196
24  54 27
(Inferior fronto-occipital
fasciculus R)
Forceps minor
Genu of corpus callosum
Splenium of corpus callosum
Cingulum bundle
(hippocampus) R
Uncinate fasciculus L
Superior longitudinal fasciculus L
Inferior longitudinal fasciculus L
Inferior fronto-occipital
fasciculus R
Posterior thalamic radiation L
Retrolenticular part of internal
capsule L
Corticospinal tract L
Corticospinal tract R
Superior corona radiata L
Superior corona radiata R
140
 24  45 34
Superior longitudinal
fasciculus L
Superior longitudinal fasciculus L
Anterior thalamic radiation L
Cingulum bundle L
Mean
diffusivity
No. of voxels and
signal peaks
(X, Y, Z)
White matter tracts
7.92±0.64 12289
 1 10 22
(Body of corpus callosum)
Forceps minor
Genu of corpus callosum
Body of corpus callosum
Splenium of corpus callosum
Cingulum bundle L
Cingulum bundle R
Uncinate fasciculus L
Superior longitudinal fasciculus L
Inferior longitudinal fasciculus L
Inferior longitudinal fasciculus R
Inferior fronto-occipital
fasciculus L
Inferior fronto-occipital
fasciculus R
Anterior thalamic radiation L
Corticospinal tract L
Corticospinal tract R
Anterior limb of internal capsule
L
Posterior limb of internal
capsule L
Superior corona radiata L
486
51  7 23
Superior longitudinal fasciculus R
In the first column, values of the DTI measures of AD and MD (means±SD) are
given for regions showing maximal effects of lithium on TBSS values (signal
peaks). The second column shows dimensions of clusters (number of voxels,
mm3) and localization of signal peaks (MNI coordinates). The third column lists
the WM tracts significantly affected by lithium in the clusters.
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